脑梗死两种治疗方案的药物经济学分析

Pharmacoeconomic analysis of 2 therapeutic schemes for cerebral infarction

目的评价应用葛根素与血塞通治疗脑梗死的疗效及成本-效果比。方法运用药物经济学成本-效果分析方法,对葛根素与血塞通治疗94例脑梗死病人的疗效及成本进行比较、分析。结果葛根素与血塞通治疗脑梗死总有效率分别为88．89％、87．76％,成本-效果比分别为 5．62、3．28。结论葛根素与血塞通均能有效治疗脑梗死,但血塞通成本-效果比优于葛根素。

Objective To compare the therapeutic effects and the cost-effectiveness between puerarin and Xuesaitong in the treatment of cerebral infarction. Methods Using pharmacoeconomic cost-effectiveness analysis, puerarin was compared with Xuesaitong in the treatment of 94 patients with cerebral infarction. Results The total effective rates of puerarin and Xuesaitong were 88.89% and 87.76%, respectively, the cost-effectiveness ratios were 5.62 and 3.28, respectively. Conclusion Both of puerarin and Xuesaitong can effectively treat cerebral infarction, but the coat-effectiveness ratio of Xuesaitong is superior to that ofpuerarin.